|
HS Code |
818479 |
| Chemical Name | 5-Aminoimidazole-4-carboxamide ribonucleoside |
| Abbreviation | AICAR |
| Cas Number | 3031-94-5 |
| Molecular Formula | C9H14N4O5 |
| Molecular Weight | 258.23 g/mol |
| Appearance | White to off-white powder |
| Solubility | Soluble in water |
| Purity | Typically >98% |
| Melting Point | 214-216 °C (decomposes) |
| Storage Temperature | 2-8°C, protected from light |
| Synonyms | Acadesine, AICA riboside |
| Ph Value | Typically 3.0-5.0 (50 mg/mL in water) |
As an accredited 5-Aminoimidazole-4-carboxamide ribonucleoside(AICAR) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | AICAR is supplied in 100 mg amber glass vials, sealed with a screw cap, labeled with product name, CAS number, and purity. |
| Shipping | The chemical 5-Aminoimidazole-4-carboxamide ribonucleoside (AICAR) is shipped in tightly sealed containers under dry, cool conditions to ensure stability. Packaging follows standard chemical safety regulations, with appropriate labeling and documentation. Shipments may require temperature control and expedited delivery to prevent degradation of the compound during transit. |
| Storage | 5-Aminoimidazole-4-carboxamide ribonucleoside (AICAR) should be stored in a tightly sealed container, protected from light, moisture, and air. It is recommended to keep AICAR at -20°C for long-term storage. Store in a dry, cool place away from incompatible substances. Always use the chemical in a well-ventilated area and follow appropriate safety protocols during handling. |
Applications of 5-Aminoimidazole-4-carboxamide ribonucleoside (AICAR) in Industrial Manufacturing5-Aminoimidazole-4-carboxamide ribonucleoside (AICAR) plays an important role in the synthesis of advanced bioactive compounds and research intermediates. As an established manufacturer, we provide AICAR for industrial clients engaged in pharmaceutical synthesis, biochemical research, cell media production, and specialty enzyme manufacturing. Below outlines the detailed downstream applications in key sectors, with process, compliance, and usage specifics. 1. Nucleoside Drug API ProductionAICAR serves as a critical intermediate for the synthesis of purine-based nucleoside APIs in the pharmaceutical industry. Our customers utilize AICAR in multi-step synthesis processes to produce investigational and approved drug substances, including anticancer and antiviral therapeutics. Manufacturers maintain strict compliance and adjust input ratios based on target compound yields and impurity profiles. AICAR integrates into the process at early-stage condensation or phosphorylation steps, driving the analog development cycle. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Biochemical Research and Cell Signaling StudiesResearchers use AICAR as a direct activator of AMP-activated protein kinase (AMPK) in laboratory investigations focused on cellular bioenergetics, metabolic disease, and signal transduction. Precise quantification and traceability govern in vitro and ex vivo experimental design. Batches destined for research applications must meet analytical reference standards, and quality control teams test for endotoxin, heavy metals, and nucleoside content. Integration occurs at experimental assay preparation, where the control of working concentrations assures data reproducibility. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Cell Culture Media SupplementationManufacturers of advanced cell culture media incorporate AICAR to enhance studies of metabolic function and differentiation. As a specialized additive, it enters the formulation at pilot or production blending stages, with precision dosing managed through inline mixing. Quality control ensures sterility, solubility, and lot-to-lot consistency as per regulatory guidance. Customers typically rely on certificates of analysis for each batch, referencing nucleoside concentrations and purity indices. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Enzyme Substrate Manufacturing for Diagnostic KitsAICAR is employed as a substrate in the industrial-scale preparation of enzymatic assay kits designed for clinical and research diagnostics. Downstream integration requires high assay purity and consistent batch matching. Manufacturers run GMP-like protocols for end-use in human diagnostics. Substrate input must align with the desired reaction curve and limit interference in multistep enzymatic processes. Automated dispensing systems introduce AICAR at the substrate plate loading stage, monitored for cross-contamination. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 5-Aminoimidazole-4-carboxamide ribonucleoside(AICAR) prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Stepping into the lab every day, we constantly revisit the basics of molecular building blocks. One compound we know inside and out is 5-Aminoimidazole-4-carboxamide ribonucleoside, more widely known as AICAR. Over the decades, our work with AICAR has illustrated both its complexity and its practical value, especially for researchers who depend on consistent quality and reliable performance in their experiments.
We’ve been producing AICAR at a purity greater than 98%, commonly as a white to off-white crystalline powder. This is not just a number on a certificate of analysis; in our industry, such purity means that researchers don’t spend cycles troubleshooting issues caused by unpredictable side materials or contaminants. Each lot we produce undergoes meticulous in-house testing using HPLC and NMR, with backup expertise in additional analytical methods, so every shipment meets the same standard of quality. Some users request material at gram or kilogram scale, and we fulfill both with the same care, recognizing that reliable research results only come from a repeatable, verified product.
Inside our facility, the talk is not about buzzwords but real impacts. AICAR stands apart for its unique role as an activator of AMP-activated protein kinase (AMPK). This property gives AICAR a central position in metabolic research. We have witnessed its use streamlining metabolic pathways studies, offering a way to precisely probe the cellular response under energy stress conditions. Unlike run-of-the-mill biochemicals that often end up as background noise in experiments, AICAR’s interaction with AMPK brings out clear, measurable shifts in downstream signaling. In scientific circles, this reproducibility translates into valuable time and credibility for researchers.
A significant aspect many overlook is batch-to-batch consistency. We’ve received a fair share of phone calls from labs burned by irregular AICAR from intermediaries or importers who couldn’t guarantee origin or process discipline. On our floor, raw materials and process parameters get logged and double-checked at every step. We source starting compounds directly from verified vendors, sometimes even growing our crystals from base chemicals in dedicated reactors. The focus here is on not just purity, but also controlling water content, crystal form, and avoiding even trace metal contamination which has been shown to kill sensitive enzyme assays.
The physical form of AICAR—powder with a typical melting point near 214–216°C, soluble in water and DMSO—eases both handling and experimental setup for users. We’ve had customers in structural biology who prefer the powder’s easy dissolution at experimental temperatures, reducing solubility headaches. Labs pushing for precise dosing in cell culture work appreciate how our product delivers predicable calibration curves.
Allergen control measures and absence of extraneous DNA or endotoxins are factored into everything we ship, so nothing outside the tested variable skews sensitive cell-based assays. Not all suppliers commit to these routine but vital controls. We find it a point of pride that our rigorous testing matches international pharmaceutical and biotech expectations, even for research-grade batches.
The global scientific effort to unravel metabolic and mitochondrial function regularly circles back to AICAR. This compound’s main claim to practical relevance stems from its role as an AMP analog. It’s not just theory; every week we talk to scientists running cell lines, animal models, or enzyme preps where activation of AMPK forms the bedrock of primary data. In metabolic research, AICAR signals for energy production and shifts in glucose uptake pathways, making it an essential component in diabetes, obesity, and exercise physiology studies. We are no strangers to seeing our AICAR referenced in papers on sarcopenia, neurodegeneration, and cancer metabolism, or even as a training control in animal physiology trials.
Because AMPK sits at the intersection of so many vital processes, the compound provides clearer answers about where signaling disruptions originate. The reliability of the molecule inspires confidence when interpreting data, given its well-documented action pathway. Our feedback from customers across academic and pharmaceutical sectors has been invaluable, guiding our improvements in both documentation and packing integrity.
A world of nucleoside analogs exists, yet few offer the same range of research insights as AICAR. While adenosine and its derivatives participate in signaling, AICAR packs a punch by acting as a direct AMPK pathway modulator. Some products, like adenosine monophosphate, simply serve as substrate for kinase reactions. Others, such as cordycepin, skew towards anti-cancer programs due to their chain-terminating properties during RNA extension. In our experience, these compounds do not reproduce AICAR’s effect in cell energy regulation or provide the same granularity in metabolic pathway analysis.
Forsaking standardization for a moment, we often see competitor samples come with undetected solvent signals or hidden impurities. AICAR’s chemistry—an imidazole core linked to a ribofuranose—lends itself to specific types of side-products during synthesis. Our team tracks and eliminates these issues, down to residual organic solvents (usually below 0.5%) and guarantees the riboside form over the base. This is not just technical; even minor changes in the impurity profile can cause inconsistency in enzyme inhibition or activation assays. In our stability chambers, we have tested the product past twelve months at variable humidity and temperature, assuring researchers of a useable window that fits real-world project cycles.
Our own work has shown AICAR keeps well when stored desiccated at -20°C. Typical vials are nitrogen-flushed and sealed to prevent moisture and oxygen ingress, often with tamper seals logged by batch. The absence of color and odor in our final product is not a side effect—it is a direct result of precision in each production round. Experience has taught us that even micro-leaks in container seals can let in humidity, causing the ribonucleoside to degrade or clump, so we inspect each final container, not only at dispatch but also with periodic retention checks.
Many labs order AICAR in small, single-use vials for dedicated experiments, but our commercial users often take bulk packs with fill details documented on certificates. For every customer, we trace supply to ensure that recalls or concern reports can be followed back to the lot with full transparency. No assumptions, only records.
Traceability emerges as a hot topic, especially as research grows more global and regulatory agencies scrutinize source documentation. We maintain transparent batch records and offer spectral data packages upon request, allowing end-users to verify identity in their own facilities using recognizable fingerprints. Smarter regulation and researcher guidance in major economies have set higher bars for chemical documentation. In some regions, oversight is more relaxed, but we do not cut corners where customers rightly expect reliability. Our approach helps eliminate ambiguity faced by scientists who have to explain anomalous data or repetition failures, which almost always trace back to untrustworthy raw materials.
Occasionally, substitutions happen in the marketplace: so-called “equivalent” materials sourced from resellers whose chain of custody is broken. We’ve investigated such products in our own lab, uncovering missing or misplaced peaks in HPLC runs, unidentified signals that alter experimental readouts. Customer confidence erodes quickly under these circumstances. Research foundations, journal reviewers, and regulatory offices now demand robust product validation. We have responded by expanding our available documentation—MSDS, IR/NMR spectra, and certificates—to include detailed analytical data, so researchers and purchasing departments alike understand what they’re getting.
We have direct lines of communication open with scientific customers to walk through proper storage, optimal handling, and creative uses that solve new problems. For example, we have consulted with university teams about AICAR’s utility in in vivo rodent models, ensuring that excipients and injection vehicles do not reduce bioavailability. This type of consultative partnership distinguishes a real manufacturer’s insight from generic distributor handoffs. Precipitation, pH adjustment, stability after thawing—these don’t appear in standard product sheets, but our support crew walks through each parameter as a matter of professional pride, because we have run the experiments ourselves.
We also keep a close pulse on developing research themes, such as AICAR’s emerging role in investigating muscle atrophy and its mechanistic links with mitochondrial biogenesis. As soon as new literature suggests expanded uses, our formulation, packaging, and documentation teams review ongoing protocols for opportunities to anticipate or resolve user bottlenecks.
It’s no secret that in the chemical supply world, not all sources are equal. As the manufacturer, we retain control from the granular chemistry of our feedstocks to the logistics of frozen transport. Working with hundreds of labs worldwide, we have seen time and again how a reliable supply of AICAR saves budgets, prevents lost experiments, and provides that elusive stability researchers hope for when reproducing critical work or scaling up for new programs.
Feedback from large pharmaceutical companies and smaller startup biotechs has provided insight into unique requirements for clinical translation, such as GMP-grade precursors and audit-traceable files. Many manufacturers claim capability in these arenas, but without machinery, staffing, and proper protocols, gaps appear rapidly. By staying true to our own processes, we help streamline both academic and applied research, bridging bench-scale discovery with commercial application.
We view every batch as a learning opportunity. Lot histories, user feedback, and even rare complaints serve as data for ongoing improvement. If a batch shows a rare insoluble fraction, it prompts an internal review of synthesis and drying protocols. We routinely update analytical protocols aligned with new pharmacopoeia or regulatory standards, ensuring what leaves our plant is always competitive. Customer requests for custom fill sizes or packaging modifications are welcome; we track industry developments for changes in usage patterns, such as novel delivery systems or integration with high-throughput drug screening.
As new research emerges around compounds structurally related to AICAR—such as ZMP analogs for AMPK-independent pathways—we anticipate incremental changes in synthesis or purification that can expand or enhance user experience. Our development chemists frequently cross-collaborate with academic partners, pooling practical data that informs complete process cycles. Newer dye-based or LC-MS analytics feed directly into refining our lot-release strategy.
AICAR carries unique value far beyond its molecular formula. Our team’s decades of collective experience with the product provide customers confidence, not just in what’s inside the bottle, but in the entire journey from raw material selection to final experiment. No amount of clever marketing replaces the insight gained from hands-on production, quality assurance, and customer collaboration.
Moving forward, we continue to focus on the deep science and real-world realities of working with critical biochemicals. Our reputation grows by helping scientists uncover metabolic mysteries, set new research standards, and trust that each sample delivered meets and exceeds expectations. For us, it’s not about volume, it’s about every batch, every experiment, and every discovery that relies on a reliable molecule made with discipline and pride.